Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Massai

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Lancet. Infectious Diseases|January 26, 2026
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trialIlse De Coster, Mohammad AbdelGhany, Eleanna Sarakinou, et al.
Human Molecular Genetics|January 18, 2014
A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's diseaseMarianne R Smith, Adeela Syed, Tamas Lukacsovich, et al.
British Journal of Clinical Pharmacology|September 17, 2014
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's diseaseSigurd D Süssmuth, Salman Haider, G Bernhard Landwehrmeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2026
SpyCEP dismantles neutrophil immunity via disorder-driven chemokine remodeling and GAG targetingRikin J Lau, Sean P Giblin, Andra Sugar, et al.
Nature Chemical Biology|April 8, 2015
siRNA screen identifies QPCT as a druggable target for Huntington's diseaseMaria Jimenez-Sanchez, Wun Lam, Michael Hannus, et al.
Nature Medicine|August 8, 2025
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden settingAlexander J Keeley, Fatoumata E Camara, Edwin P Armitage, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Lancet. Infectious Diseases|January 26, 2026
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trialIlse De Coster, Mohammad AbdelGhany, Eleanna Sarakinou, et al.
Human Molecular Genetics|January 18, 2014
A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's diseaseMarianne R Smith, Adeela Syed, Tamas Lukacsovich, et al.
British Journal of Clinical Pharmacology|September 17, 2014
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's diseaseSigurd D Süssmuth, Salman Haider, G Bernhard Landwehrmeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2026
SpyCEP dismantles neutrophil immunity via disorder-driven chemokine remodeling and GAG targetingRikin J Lau, Sean P Giblin, Andra Sugar, et al.
Nature Chemical Biology|April 8, 2015
siRNA screen identifies QPCT as a druggable target for Huntington's diseaseMaria Jimenez-Sanchez, Wun Lam, Michael Hannus, et al.
Nature Medicine|August 8, 2025
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden settingAlexander J Keeley, Fatoumata E Camara, Edwin P Armitage, et al.
Pageof 3